Filter
1911
Filtered Results: 1911
Text search:
molecular
Featured
Recommendations
224
New Publications
349
Language
Document type
No document type
835
Guidelines
440
Studies & Reports
330
Manuals
112
Strategic & Response Plan
79
Fact sheets
53
Training Material
23
Situation Updates
17
Infographics
10
Resource Platforms
9
Videos
2
Brochures
1
Countries / Regions
India
95
Latin America and the Carribbean
72
Global
64
Brazil
62
Western and Central Europe
61
Africa
43
Eastern Europe
36
Germany
34
Kenya
30
Colombia
30
South Africa
28
Argentina
25
Senegal
23
Ethiopia
22
Tanzania
22
Peru
22
West and Central Africa
22
Venezuela
20
East and Southern Africa
19
Russia
18
Congo, Democratic Republic of
17
El Salvador
17
Mozambique
16
Paraguay
15
Uganda
14
Rwanda
14
South–East Asia Region
14
Sierra Leone
13
Bolivia
13
Nigeria
12
Malawi
12
Philippines
11
Nepal
10
Angola
10
Chile
10
Asia
10
Cameroon
9
Zambia
9
Ukraine
9
Ecuador
9
Burkina Faso
8
Liberia
8
Indonesia
8
Middle East and North Africa
8
Ghana
7
Haiti
7
Bangladesh
7
Namibia
7
Spain
7
Zimbabwe
6
Syria
6
Guinea
5
Benin
5
Myanmar / Burma
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
France
5
Mali
4
Guinea-Bissau
4
Côte d’Ivoire / Ivory Coast
4
USA
4
Pakistan
4
Madagascar
4
Italy
4
Vietnam
4
Niger
3
Lebanon
3
Chad
3
Cambodia
3
Eswatini/ Swaziland
3
Botswana
3
Uruguay
3
Morocco
2
Saudi Arabia
2
Togo
2
Somalia
2
South Sudan
2
Iraq
2
Jordan
2
Turkey
2
Thailand
2
China
2
Mauritania
2
Dominican Republic
2
Honduras
2
Libya
2
Guatemala
2
Congo-Brazzaville
2
Tajikistan
2
Georgia
2
North America
2
United Kingdom
2
Portugal
2
Afghanistan
1
Egypt
1
Gambia
1
Malaysia
1
Sudan
1
Central African Republic
1
North Macedonia
1
Switzerland
1
Cuba
1
Burundi
1
Lesotho
1
Mexico
1
Nicaragua
1
Yemen
1
Luxembourg
1
Palestine
1
Djibouti
1
Canada
1
Timor Leste/ East Timor
1
Qatar
1
Estonia
1
Romania
1
Kazakhstan
1
Turkmenistan
1
Japan
1
Belgium
1
Tunisia
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
663
Clinical Guidelines
247
Public Health
82
Pharmacy & Technologies
68
Key Resources
31
Women & Child Health
25
Capacity Building
6
Toolboxes
TB
411
COVID-19
305
AMR
117
NTDs
116
Rapid Response
88
HIV
88
Mental Health
81
Ebola
57
Planetary Health
47
Zika
35
Pharmacy
33
NCDs
27
Refugee
24
Caregiver
18
Polio
16
Specific Hazards
11
Cholera
10
Global Health Education
9
Disability
8
Health Financing Toolbox
6
Conflict
5
Natural Hazards
4
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
This handbook is intended primarily for front-line health care providers who are likely to see children (among other clients) in their day-to-day practice. These may include general practitioners, nurses, midwives, gynaecologists,
paediatricians, mental health professionals, first responders and st...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Un comité OMS d’experts sur la trypanosomiase humaine africaine (THA) : lutte et surveillance, s’est réuni à Genève (Suisse), du 22 au 26 avril 2013. Le Dr H. Nakatani, sous-directeur général pour le VIH/SIDA, la tuberculose, le paludisme et les maladies tropicales négligées, a ouvert la...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
Yaws is a disfiguring non-venereal disease caused by infection with the spirochaete. Treponema pallidum subspecies pertenue which is closely related to the causative agent of syphilis and those of the other endemic treponematoses, bejel and pinta. The disease is endemic in certain areas of the World...
In response to the recent publication “Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes” by Dadzie et al., it is important to clarify and highlight the positive and unequivocal research and operational contributio...
Leptospirosis is a bacterial zoonotic disease of worldwide importance, though relatively neglected in many African countries including sub Saharan Africa that is among areas with high burden of this disease. The disease is often mistaken for other febrile illnesses such as dengue, malaria, rickettsi...
Leptospirosis, a spirochaetal zoonosis, occurs in diverse epidemiological settings and affects vulnerable populations, such as rural subsistence farmers and urban slum dwellers. Although leptospirosis is a life-threatening disease and recognized as an important cause of pulmonary haemorrhage syndrom...
Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.
Chromoblastomycosis (CMB) is a chronic fungal infection of the skin and the subcutaneous tissue caused by a transcutaneous traumatic inoculation of a specific group of dematiaceous fungi occurring mainly in tropical and subtropical zones worldwide. If not diagnosed at early stages, patients with CBM...
Scabies is a skin infection that is a result of direct skin to skin contact and is primarily mediated by close and extended contact with scabies infested person. Scabies occurs worldwide among people of all ages, races, genders and social classes and has been identified as a neglected tropical infec...
Several Public Health Services and general practitioners in the Netherlands observed an increase in scabies in the Netherlands. Since individual cases of scabies are not notifiable in the Netherlands, the epidemiological situation is mostly unknown. To investigate the scabies incidence in the Nether...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti...
